Author:
Cai Li-yi,Abe Masanobu,Izumi Shun-ichiro,Imura Masayoshi,Yasugi Toshiharu,Ushijima Toshikazu
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference31 articles.
1. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas;Abe;Cancer Research,2005
2. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours;Agathanggelou;Oncogene,2001
3. BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study;Baldwin;Cancer Research,2000
4. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades;Barnholtz-Sloan;American Journal of Obstetrics and Gynecology,2003
5. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors;Esteller;Journal of the National Cancer Institute,2000
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献